Navigation Links
Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
Date:9/20/2010

cal industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulatory action or lawsuits relating to our use of controlled substances in many of our core products; our exposure to product liability claims and product recalls and the possibility that we may not be able to adequately insure ourselves; our ability to protect our proprietary technology; our ability to successfully implement our in-licensing and acquisition strategy; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by the government; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of our total net sales; a determination by a regulatory agency that we are engaging in inappropriate sales or marketing activities, including promoting the "off-label" use of our products; the loss of branded product exclusivity periods and related intellectual property; and exposure to securities that are subject to market risk including auction-rate securities the market for which is currently illiquid; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended Dec. 31, 2009, which was filed with the Securities and Exchange Commission on Feb. 26, 2010. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and h
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
2. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
3. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
4. HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
5. Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
6. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
7. ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
8. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
9. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
11. Access Pharmaceuticals Launches MuGard Product Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the ... The psychological and physical side effects of pain ... opioid painkillers, such as Vicodin and Oxycontin, are safer ... Americans overdose on prescription painkillers than on heroin and ... and CEO of NSC. "Yet, these medications are marketed ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... be useful in treatment for degenerative disc disease LAS VEGAS, ... disease, sends millions of people to their doctor. In fact, ... do so because of disc degeneration. And part of the ... In their quest to discover ways to stop or reverse ...
... HARRISBURG, Pa., Feb. 20 Health ... grants totaling nearly $18 million will be awarded ... for 2008-09.These competitive grants focus on specific research ... Health Research Advisory Committee, chaired by Secretary James. ...
Cached Medicine Technology:Aching Back? Cholesterol Medication Might Help 2Aching Back? Cholesterol Medication Might Help 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4
(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... 2015 A study out of the ... therapy procedure for the treatment of a hereditary ocular ... Authored by Dr. Robert MacLaren, professor of ophthalmology ... Lancet Medical Journal on January 16, 2014 , the ... genetic disorder that mostly affects men and leads to ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be ... Materials Show, an annual, premier sustainable building event in ... top manufacturers of the latest building products, services and ... and manufactured by Pioneer Millworks from their Oregon and ... restaurants, hotels, retailers, and corporate offices. Nichibi Global ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 India ... has sponsored visitor health insurance programs for visitors coming ... Most Indian elderly parents traveling to the United States ... as diabetes and blood pressure. These diseases are so ... even list them as medical conditions. There were 66.8 ...
(Date:2/28/2015)... How would you describe your leadership ... all kinds of different leaders, each with their ... advantages and applications of different leadership styles, Ohio-based ... product this spring called The Leadership Report that ... personality type, leadership, and success. The Leadership Report ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... to a new study by researchers from Netherlands the ... affected areas into larger portions of the brain, which ... research led by Hugo Vrenken, Ph.D., from the Multiple ... who have published their findings that is scheduled to ...
... University of Georgia have conducted a new study that gives ... body react to parasitic diseases that affect scores of people ... at the University of Georgia, that has been just published ... open-access journal published by the Public Library of Science, states ...
... The wife of an ailing Parkinson’s patient has challenged the view ... medical emergency care alarm service, which the// Scottish public service refuses ... the ruling is a target at the weaker sections of the ... the elderly. ,Mrs. C had installed the emergency ...
... whose brain damage at birth has turned him into a ... parents hold guilty, but that is of// little use to ... has ordered the Cosmopolitan Hospital here and two doctors to ... Naveen Thomas, holding them responsible for medical negligence. The money ...
... ad campaign blaming GOP lawmakers for not seeking lower ... launched by the// Association of Trial Lawyers of America ... lawmakers for blocking provisions that would have required Medicare ... cost has been targeted against the Republican House members ...
... were cancelled by 34 hospitals across the State according to ... hospitals thousands of patients had their operations cancelled because the ... surgery in 2005 had no vacant beds. ,The ... 4,281 operations last year. Of these some 3,598 were said ...
Cached Medicine News:Health News:Damage Due to MS Might Extend Into Larger Portions Of The Normal Brain 2Health News:An All Important Breakthrough Reached In Understanding T cell response For Parasitic Diseases 2Health News:An All Important Breakthrough Reached In Understanding T cell response For Parasitic Diseases 3Health News:Brain Defect boy Compensated for Medical Error 2Health News:Brain Defect boy Compensated for Medical Error 3Health News:Ad Campaign Targeting Republicans On Medicare Prescription Drug Program 2Health News:Cancellations of Operations touch 22,000 2
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum....
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
Medicine Products: